In patients with severe clinical manifestations, high levels of aspartate (AST) and alanine aminotransferases (ALT), thrombocytopenia, and a multifactorial bleeding disorder caused by reduced synthesis of clotting factors are usually observed. This evidence concerns the gene GPT and Thrombocytopenia.